News for 'Serum Institute'

'Around 100 million doses will definitely be wasted'

'Around 100 million doses will definitely be wasted'

Rediff.com13 Aug 2022

'We are trying to salvage 50-100 million doses of Covishield with the latest drive on booster doses.'

Coming Soon, New Ways To Vaccinate

Coming Soon, New Ways To Vaccinate

Rediff.com3 Sep 2022

'Just put a patch on your arm and the vaccine can be absorbed by the body.'

Dom's Take: India, here comes the vaccine!

Dom's Take: India, here comes the vaccine!

Rediff.com15 Jan 2021

Dominic Xavier salutes every single person involved in making this miracle possible.

Biocon Biologics Plan Molecule Launch Every 1-2 Years

Biocon Biologics Plan Molecule Launch Every 1-2 Years

Rediff.com17 Aug 2022

'The tie-up with Serum Institute Life Sciences brings to the table their strengths in manufacturing and also their vaccine portfolio.'

AstraZeneca admits in court: Covishield causes TTS

AstraZeneca admits in court: Covishield causes TTS

Rediff.com30 Apr 2024

United Kingdom-headquartered pharmaceutical giant AstraZeneca (AZ) has admitted that in 'very rare cases' its Covid vaccine can cause a blood clot related side effect but the causal link is unknown, according to court papers being quoted in the UK media.

With Rs 11.6 lakh cr wealth, Adani replaces Ambani as India's richest

With Rs 11.6 lakh cr wealth, Adani replaces Ambani as India's richest

Rediff.com29 Aug 2024

Recouping the dent caused by the Hindenburg Research report, Gautam Adani's networth shot up 95 per cent to Rs 11.6 lakh crore last year, which helped him replace Mukesh Ambani to become the richest Indian, a report said on Thursday. Reliance Industries chairman and managing director Ambani's overall networth increased by 25 per cent to Rs 10.14 lakh crore, as per the 2024 Hurun India Rich List. In 2023's report, Adani's wealth declined by 57 per cent to Rs 4.74 lakh crore, and Ambani was way ahead with a fortune of Rs 8.08 lakh crore.

His wealth grew the fastest in India during pandemic

His wealth grew the fastest in India during pandemic

Rediff.com23 Jun 2020

Pune-based entrepreneur's unlisted company is already the largest vaccine manufacturer in the world and the networth has been helped by vaccine distribution and manufacturing potential of his business, it added. Recentrly, Serum struck an agreement with AstraZeneca to manufacture 1 billion doses of coronavirus vaccine being developed by Oxford University.

Serum, Bharat Bio seek govt funds to boost vaccine output

Serum, Bharat Bio seek govt funds to boost vaccine output

Rediff.com5 Apr 2021

Both manufacturers have sought funds in excess of Rs 150 crore under the department of biotechnology's Mission Covid Suraksha scheme. Announced last November, the scheme has an outlay of Rs 900 crore to help develop Covid vaccines, from the clinical development stage to setting up production sites.

Look Who's Following Karan Johar's Footsteps!

Look Who's Following Karan Johar's Footsteps!

Rediff.com20 Nov 2024

Siddharth Roy Kapur's RKF aims to raise around $50 million by offering up to a 50 per cent stake in the company.

New-Gen COVID Jabs Coming Soon...

New-Gen COVID Jabs Coming Soon...

Rediff.com28 May 2024

India currently does not have any XBB 1.5 variant-based vaccines available.

Serum gets nod for phase 2, 3 trials of Covid vaccine in India

Serum gets nod for phase 2, 3 trials of Covid vaccine in India

Rediff.com3 Aug 2020

Currently, phase 2 and 3 clinical trials of the Oxford vaccine candidate is going on in the United Kingdom, phase 3 clinical trial in Brazil and phase 1 and 2 clinical trials in South Africa.

Bold Moves Must For Silver Screen To Sparkle Again

Bold Moves Must For Silver Screen To Sparkle Again

Rediff.com12 Jul 2025

More screens, more films, and longer windows will convert to more people watching, assuming they know a film is releasing, points out Vanita Kohli-Khandekar.

PM to meet 7 Indian Covid vax manufacturers today

PM to meet 7 Indian Covid vax manufacturers today

Rediff.com23 Oct 2021

Representatives from seven vaccine makers -- Serum Institute of India, Bharat Biotech, Dr Reddy's Laboratories, Zydus Cadila, Biological E, Gennova Biopharma and Panacea Biotech -- will be participating in the meeting.

How Serum and Bharat battled for COVID-19 vaccine

How Serum and Bharat battled for COVID-19 vaccine

Rediff.com23 Apr 2021

There were apprehensions in the SII about rival Bharat Biotech's 'indigenous' tag, opening up shortcuts for it. One senior person, who was very familiar with the sector, told me, 'The message has gone out from the very top. Somani (V G Somani -- drug controller general of India) has told me "Bharat ka karna hai".' A fascinating excerpt from Abantika Ghosh's Billions Under Lockdown: The Inside Story Of India's Fight Against COVID-19.

No decision on granting indemnity to any vaccine producer yet: Govt

No decision on granting indemnity to any vaccine producer yet: Govt

Rediff.com4 Jun 2021

No decision on granting indemnity to any foreign or Indian Covid vaccine-manufactures has been taken yet, the government said Friday, underlining these decisions are to be taken 'in the interest of nation and people'.

Two doses of vaccine will be needed 28 days apart: Govt

Two doses of vaccine will be needed 28 days apart: Govt

Rediff.com12 Jan 2021

Addressing a press briefing, Union Health Secretary Rajesh Bhushan said vaccine effectiveness will be seen only after 14 days.

Private hospitals may import Covid vaccines

Private hospitals may import Covid vaccines

Rediff.com15 May 2021

Apollo Hospitals and Fortis Healthcare are open to importing vaccines.

Reliance, Tata on TIME's list of world's most influential companies

Reliance, Tata on TIME's list of world's most influential companies

Rediff.com30 May 2024

Billionaire Mukesh Ambani's Reliance Industries and Tata Group have made it to the prestigious TIME's list of 100 World's Most Influential Companies of 2024. TIME called Reliance 'India's Juggernaut'. This is the second time that Reliance has found its way into the TIME list. Jio Platforms, the firm that holds digital properties of the conglomerate, was included in the inaugural TIME 100 Most Influential Companies List of 2021. Serum Institute is the other Indian company on the list.

54.72 L COVID vaccine doses received till Tuesday afternoon: Centre

54.72 L COVID vaccine doses received till Tuesday afternoon: Centre

Rediff.com12 Jan 2021

Apart from the 1.1 crore doses of Covishield being procured from the Serum Institute of India, 55 lakh doses of indigenously developed Covaxin were being obtained from Bharat Biotech, Union Health Secretary Rajesh Bhushan said at a press conference.

DCGI approves Covovax for emergency use in 12-17 yrs age group

DCGI approves Covovax for emergency use in 12-17 yrs age group

Rediff.com9 Mar 2022

Confirming the Drugs Controller General Of India (DCGI) approval, Serum Institute of India CEO Adar Poonawalla on Tuesday tweeted: '@SerumInstIndia's brand Covovax has completed bridging studies in India and has been granted Emergency Use Authorisation by DCGI for adults and for children above the age of 12. Younger age groups will follow shortly.'

India approves Oxford's, Bharat Biotech's vaccines for emergency use

India approves Oxford's, Bharat Biotech's vaccines for emergency use

Rediff.com3 Jan 2021

The approval by the Drugs Controller General of India (DCGI) was given on the basis of recommendations submitted by a COVID-19 subject expert committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO).

'Bharat Serums and Vaccines portfolio can touch Rs 5K cr in 3-4 years'

'Bharat Serums and Vaccines portfolio can touch Rs 5K cr in 3-4 years'

Rediff.com9 Aug 2024

'Mankind's experience, sharpness, and execution will make it happen. We are not going for short-term gains.'

Expert panel seeks more data on SII, Bharat Biotech vaccines

Expert panel seeks more data on SII, Bharat Biotech vaccines

Rediff.com10 Dec 2020

An expert committee of the Central Drugs Standard Control Organisation (CDSCO) on Wednesday sought additional safety and efficacy data for COVID-19 vaccine candidates of Serum Institute and Bharat Biotech, after deliberating upon their applications seeking emergency use authorisation for the shots, official sources said.

DCGI approves mRNA Covid jab for 18 yrs & above; Covovax for 7-11 yrs

DCGI approves mRNA Covid jab for 18 yrs & above; Covovax for 7-11 yrs

Rediff.com28 Jun 2022

The DCGI's nod came after the subject expert committee on COVID-19 of the CSDCO last week recommended granting emergency use authorisation to Covovax for the age group of 7 to 11 years.

'We put pressure on Biden admn over vaccines'

'We put pressure on Biden admn over vaccines'

Rediff.com13 May 2021

'Supplies should start moving to the Serum Institute without any impediments.'

'Aggression over Covid vaccines is unprecedented'

'Aggression over Covid vaccines is unprecedented'

Rediff.com1 May 2021

CEO of Serum Institute of India hints that he may start producing in Britain and speaks about threatening calls from the rich and powerful

Govt panel seeks additional data from SII on Covovax

Govt panel seeks additional data from SII on Covovax

Rediff.com28 Nov 2021

The Serum Institute of India (SII) had put in an application to the Drugs Controller General of India (DCGI) in October for grant of market authorisation of Covovax for restricted use in emergency situations.

Sharad Pawar should retire now, he is ageing, says close friend Poonawalla

Sharad Pawar should retire now, he is ageing, says close friend Poonawalla

Rediff.com30 Aug 2023

NCP president Sharad Pawar may be busy getting ready for the INDIA Opposition bloc meeting in Mumbai with other Maha Vikas Aghadi (MVA) constituents, but his close friend and industrialist Dr Cyrus Poonawalla has a piece of advice for the octogenarian leader.

PM reviews vaccine work in Ahmedabad, Hyderabad and Pune

PM reviews vaccine work in Ahmedabad, Hyderabad and Pune

Rediff.com28 Nov 2020

Ahmedabad was the first stop in the PM's three city tour today, to personally review the vaccine development and manufacturing process in the country.

5 Indians in Forbes Asia's Heroes of Philanthropy list

5 Indians in Forbes Asia's Heroes of Philanthropy list

Rediff.com12 Jul 2016

The Sampark Foundation boasts of a $100 million outlay funded entirely by the Nayars and represents more than half of their wealth.

PM to visit 3 COVID-19 vaccine development sites on Saturday

PM to visit 3 COVID-19 vaccine development sites on Saturday

Rediff.com27 Nov 2020

Modi on Saturday will embark on a three-city tour to take stock of the COVID-19 vaccine development work.

Hopeful of launching Covovax by Oct: Adar Poonawalla

Hopeful of launching Covovax by Oct: Adar Poonawalla

Rediff.com6 Aug 2021

On production capacity of Covishield, the vaccine being manufactured and supplied by Serum in India under a licensing agreement with Oxford and AstraZeneca, he said the present capacity is 130 million doses per month and always try to increase it further.

What Poonawalla said on vaccine, current Covid strain

What Poonawalla said on vaccine, current Covid strain

Rediff.com22 Apr 2023

Poonawalla was talking to media persons amid rising cases of coronavirus infections in the country since March.

Covid-19 impact: Low interest loans likely for vaccine companies

Covid-19 impact: Low interest loans likely for vaccine companies

Rediff.com10 Oct 2020

While there has been no commitment from the government on the procurement of vaccines, initial volumes, or distribution plans, there is a likelihood that the low interest loans may be made available to these players only when the time to scale up manufacturing arises.

Dom's Take: The Vaccine Dilemma

Dom's Take: The Vaccine Dilemma

Rediff.com9 Jan 2021

Dominic Xavier ponders the Vaccine Dilemma: Should he take the shot or not?

Star Wars Queen Natasha Poonawalla Wows Folks in New York

Star Wars Queen Natasha Poonawalla Wows Folks in New York

Rediff.com5 May 2023

Take a bow Natasha for looking so unignorable.

A Breakthrough In Nipah Virus Research

A Breakthrough In Nipah Virus Research

Rediff.com5 Jun 2024

This will also help test the effectiveness of preventing the entry of Nipah in target cells.

No more additional restrictions for flyers from UK

No more additional restrictions for flyers from UK

Rediff.com13 Oct 2021

Earlier this month, India had said that all British nationals arriving in India from the UK will have to undergo a mandatory 10-day quarantine if they are fully vaccinated against COVID-19.

PM to meet with CMs on Monday over Covid vaccine roll-out

PM to meet with CMs on Monday over Covid vaccine roll-out

Rediff.com8 Jan 2021

This will be Modi's first interaction with chief ministers following the recent approval of two coronavirus vaccines for restricted emergency use by India's drug regulator.

Preliminary data shows Vaxzevria booster works against Omicron: AstraZeneca

Preliminary data shows Vaxzevria booster works against Omicron: AstraZeneca

Rediff.com13 Jan 2022

The study also noted that the booster dosage of the company's COVID-19 vaccine Vaxzevria also increased the immune response to Beta, Delta, Alpha and Gamma SARS-CoV-2 variants.